iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Download App
image

Promoter/Promoter Group of JSW Energy Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Gufic Biosciences Limited has informed the Exchange about press release dated 11-Apr-2022 titled Gufic receives permission from CDSCO to manufacture and sale Isavuconazonium Sulfate API and Finished formulation Isavuconazole for Injection 200 mg/vial

image

Systematix Corporate Services Limited (Manager to the offer) has informed the Exchange about copy of Post - Offer Advertisement in accordance with Regulation 18(12) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the Public Shareholders of ISMT Ltd (Target Company).

image

Promoter/Promoter Group of Sigachi Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of Mangalore Refinery and Petrochemicals Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of Hindustan Media Ventures Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of Texmaco Rail & Engineering Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of Pilani Investment and Industries Corporation Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of Exide Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

image

Promoter/Promoter Group of JHS Svendgaard Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.